This finding corresponds with some of our previous work in this cohort of individuals with obesity, with reduced insulin response to an oral glucose tolerance test in those consuming breakfast relative to those fasting during the 6‐week intervention 24. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.